Market Overview

15 Biggest Mid-Day Gainers For Tuesday

  • Avenue Therapeutics Inc (NASDAQ: ATXI) shares gained 32 percent to $7.92. Avenue Therapeutics priced its 5.5 million share IPO at $6.00 per share.
  • Chicago Bridge & Iron Company N.V. (NYSE: CBI) shares surged 19.2 percent to $17.16. Delaware Supreme Court ruled in favor of Chicago Bridge & Iron in dispute with Westinghouse Electric, Reuters reported.
  • Strongbridge Biopharma plc (NASDAQ: SBBP) shares climbed 12.6 percent to $6.70 as the company disclosed that it has completed its enrollment target of 90 patients in the Phase 3 SONICS study evaluating RECORLEV™ for the treatment of endogenous Cushing’s syndrome.
  • Zion Oil & Gas, Inc. (NASDAQ: ZN) shares rose 12.6 percent to $3.12.
  • Handy & Harman Ltd (NASDAQ: HNH) shares jumped 11.8 percent to $31.85 after Steel Partners Holdings LP (NYSE: SPLP) agreed to acquire the remaining outstanding shares of Handy & Harman.
  • Cobalt International Energy, Inc. (NYSE: CIE) shares rose 10.7 percent to $2.68.
  • SurModics, Inc. (NASDAQ: SRDX) climbed 10.2 percent to $27.83. Aegis Capital initiated coverage on SurModics with a Buy rating.
  • CARBO Ceramics Inc. (NYSE: CRR) shares surged 7.7 percent to $6.86.
  • Amarin Corporation plc (ADR) (NASDAQ: AMRN) shares gained 6.2 percent to $3.66. Cantor Fitzgerald assumed coverage on Amarin with an Overweight rating and a price target of $10.00.
  • Sprint Corp (NYSE: S) shares rose 5.6 percent to $8.46 after Wall Street Journal reported a possible wireless partnership with Charter and Comcast.
  • NxStage Medical, Inc. (NASDAQ: NXTM) shares gained 5 percent to $24.58. Craig-Hallum initiated coverage on NxStage Medical with a Buy rating.
  • Affimed NV (NASDAQ: AFMD) shares climbed 4.7 percent to $2.25. Affimed presented preclinical data for AFM24 and AFM26 programs at the EACR-AACR-SIC 2017.
  • J C Penney Company Inc (NYSE: JCP) rose 4.7 percent to $4.89. Gordon Haskett upgraded J C Penney from Reduce to Hold.
  • Darden Restaurants, Inc. (NYSE: DRI) gained 4.6 percent to $94.21 after the company reported stronger-than-expected results for its fourth quarter.
  • Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) rose 4.4 percent to $15.75. Citigroup initiated coverage on Arena Pharmaceuticals with a Buy rating.

Related Articles (AMRN + AFMD)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Markets Analyst Ratings Movers

Latest Ratings

AYLANoble Capital MarketsInitiates Coverage On29.0
SHOPSusquehannaInitiates Coverage On950.0
SICraig-HallumInitiates Coverage On50.0
WORKStephens & Co.Downgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at